Ekaterina Bezverkhniaia

10PUBLICATIONS
18CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical molecular engineering of nucleic acids and proteinsPredictive and prognostic markersMolecular targetsPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Feb 27, 2026
Efficient 68Ga Labeling of a B7-H3-Targeting Affibody Molecule via Acyclic Tris(hydroxypyridinone) Chelator: Effects on Biodistribution in a Preclinical Model.

Vladimir Tolmachev, Amelinda Janice Herlina, Eleftherios Papalanis

|Oct 16, 2025
Preclinical Positron Emission Tomography Imaging of B7-H3 Expression Using Affibody Molecules Labeled with Gallium-68.

Vladimir Tolmachev, Ekaterina A Bezverkhniaia, Eleftherios Papalanis

|Oct 16, 2025
Reduction of Negative Charge in Mercaptoacetyl-Based Chelators Influences the Biodistribution of Prostate-Specific Membrane Antigen-Targeting Pseudopeptides Labeled with Technetium-99m.

Ekaterina Bezverkhniaia, Panagiotis Kanellopoulos, Ulrika Rosenström

|Mar 20, 2025
Impact of Radiometal Chelates on In Vivo Visualization of Immune Checkpoint Protein Using Radiolabeled Affibody Molecules.

Vladimir Tolmachev, Eleftherios Papalanis, Ekaterina A Bezverkhniaia

|Apr 13, 2024
Influence of Molecular Design on the Tumor Targeting and Biodistribution of PSMA-Binding Tracers Labeled with Technetium-99m.

Ekaterina Bezverkhniaia, Panagiotis Kanellopoulos, Ulrika Rosenström

Pageof 2